Relative mitogenic activities of wild-type and retinoblastoma binding-defective SV40 T antigens in serum-deprived and senescent human diploid fibroblasts.

A novel gene transfer approach was used to investigate whether the retinoblastoma (Rb)-binding domain of simian virus 40 (SV40) T antigen is required for efficient T antigen-mediated stimulation of DNA synthesis is quiescent or senescent human embryo fibroblasts. In senescent cells, comparison between wild-type T antigen and a mutant defective in Rb binding (Glu-107-->Lys) revealed the latter to have approximately 15-fold lower activity. In contrast, comparison of wild-type and Rb- T antigens in serum-deprived quiescent cells revealed a much smaller (1.8-fold) difference. Surprisingly, an 18-fold differential could be induced by treating quiescent cells with the differentiating agent sodium butyrate. These results suggest that the role of Rb in control of the cell cycle is strongly dependent on the physiological state of the cell and the mechanism of growth arrest.
AuthorsK Sakamoto, T Howard, V Ogryzko, N Z Xu, C C Corsico, D H Jones, B Howard
JournalOncogene (Oncogene) Vol. 8 Issue 7 Pg. 1887-93 (Jul 1993) ISSN: 0950-9232 [Print] England
PMID8390037 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antigens, Polyomavirus Transforming
  • Butyrates
  • Mitogens
  • Receptors, Interleukin-2
  • Retinoblastoma Protein
  • Butyric Acid
  • DNA
  • Antigens, Polyomavirus Transforming (genetics, metabolism, physiology)
  • Butyrates (pharmacology)
  • Butyric Acid
  • Cell Cycle
  • Cell Division
  • Cellular Senescence
  • DNA (biosynthesis)
  • Fibroblasts
  • Humans
  • Mitogens (physiology)
  • Mutation
  • Receptors, Interleukin-2 (genetics)
  • Retinoblastoma Protein (metabolism)
  • Simian virus 40 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: